# Vadivarhe Speci (NSE: VSCL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/VSCL · Pivot · prices to 21 Oct 2026

Vadivarhe Speci (NSE: VSCL) closed at ₹24.90 on 21 Oct 2026. With a market capitalisation of ₹37 Cr, it ranks 3253rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector.

Its return on equity was 0.0% in FY25. Over the past year the share price has fallen 62.0%. Its 52-week range is ₹16.05 (29 Dec 2025) to ₹31.80 (2 Jul 2026); the last close is 21.7% below the high. In Q4 FY22, the quarter ended 31 Mar 2022, revenue was ₹6 Cr (−28.2% year on year) and net profit −₹3 Cr, on a standalone basis. Promoters held 71.73% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹24.90 |
| Market cap | ₹37 Cr |
| ROE | 0.0% (FY25) |
| ROCE | −39.0% (FY25) |
| Debt to equity | -12.98 |
| 52-week high | ₹31.80 (2 Jul 2026) |
| 52-week low | ₹16.05 (29 Dec 2025) |
| 1-year return | −62.0% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY22 | ₹6 Cr | −28.2% | −₹3 Cr | — | −₹2.11 |
| Q3 FY22 | ₹6 Cr | +30.7% | −₹3 Cr | — | −₹2.27 |
| Q2 FY22 | ₹6 Cr | — | −₹2 Cr | — | −₹1.68 |
| Q1 FY22 | ₹4 Cr | — | −₹2 Cr | — | −₹1.46 |
| Q4 FY21 | ₹8 Cr | — | −₹1 Cr | — | −₹0.60 |
| Q3 FY21 | ₹4 Cr | — | −₹1 Cr | — | −₹0.73 |
| Q2 FY19 | ₹6 Cr | −8.4% | ₹0 Cr | −87.9% | — |
| Q1 FY19 | ₹8 Cr | +15.5% | ₹1 Cr | +335.7% | ₹0.48 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹38 Cr | −₹9 Cr |
| FY24 | ₹40 Cr | ₹0 Cr |
| FY23 | ₹44 Cr | ₹1 Cr |
| FY22 | ₹21 Cr | −₹10 Cr |
| FY21 | ₹26 Cr | −₹3 Cr |
| FY20 | ₹29 Cr | −₹10 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 71.73%
- Non-institutions: 28.27%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Crestchem](https://app.pivotnow.in/stock/CRSTCHM) | — | ₹42 Cr | — | — |
| [ZR2 Bioenergy](https://app.pivotnow.in/stock/ZR2) | — | ₹42 Cr | — | — |
| [Shiva Global](https://app.pivotnow.in/stock/SHIVAAGRO) | ₹38.00 | ₹38 Cr | — | — |
| [Seya Industries](https://app.pivotnow.in/stock/SEYAIND) | ₹12.23 | ₹32 Cr | — | — |
| [Mapro Ind](https://app.pivotnow.in/stock/MAPROIN) | — | ₹32 Cr | — | — |
| [Daikaffil Chem](https://app.pivotnow.in/stock/DAIKAFFI) | — | ₹31 Cr | — | — |

## Questions and answers

### What is the share price of Vadivarhe Speci today?

Vadivarhe Speci (NSE: VSCL) last closed at ₹24.90 on 21 Oct 2026. Its 52-week high is ₹31.80 and its 52-week low is ₹16.05.

### What is the market cap of Vadivarhe Speci?

Vadivarhe Speci's market capitalisation is ₹37 Cr (₹37 Cr) at the 22 Oct 2026 close, ranking 3253rd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Vadivarhe Speci?

Return on equity was 0.0% in FY25 and return on capital employed was −39.0% in FY25 (standalone figures).

### Is Vadivarhe Speci a debt-free company?

Vadivarhe Speci is close to debt-free: its debt-to-equity ratio was -12.98 in FY25.

### What were Vadivarhe Speci's latest quarterly results?

For Q4 FY22 (quarter ended 31 Mar 2022), Vadivarhe Speci reported revenue of ₹6 Cr, −28.2% year on year, and net profit of −₹3 Cr.

### How has Vadivarhe Speci stock performed over the last year?

Vadivarhe Speci's share price has fallen 62.0% over the past year, −6.6% over three months and +15.0% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Vadivarhe Speci?

As of 30 Jun 2026: promoters 71.73%, non-institutions 28.27%.

### Who are Vadivarhe Speci's competitors?

The listed Chemicals companies closest to Vadivarhe Speci by market cap are Crestchem, ZR2 Bioenergy, Shiva Global, Seya Industries, Mapro Ind and Daikaffil Chem.

### Is Vadivarhe Speci a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Vadivarhe Speci's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VSCL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.